Longitudinal assessment of the ultrasound gout lesions using the validated OMERACT semi-quantitative scoring system. c


Background In gout, ultrasound (US) is a promising tool to detect changes in monosodium urate (MSU) depositions during urate-lowering therapy (ULT). The OMERACT US group has developed definitions of gout-specific US lesions[1] and a semi-quantitative scoring system for US lesions representing MSU deposition (tophus, double contour (DC) and aggregates)[2], but the responsiveness of lesions when applying this scoring system has not yet been assessed.

Original languageEnglish
Publication date2022
Publication statusPublished - 2022
EventEULAR 2022 - Copenhagen
Duration: 1 Jun 20224 Jun 2022


ConferenceEULAR 2022

Cite this